Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 5/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.79 |
| ▸ | FAAH | O00519 | 1/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.79 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 3/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | CRHBP | P24387 | 1/20 | 0.55 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | BCHE | P06276 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Desmedipham SCHEMBL4659769 | 0.98 | MAPK1 (0.75) | MAPK1ALDH1A1FAAHCYP3A4MTNR1B | |
| SCHEMBL134424 | 0.93 | MAPK1 (0.77) | MAPK1ALDH1A1FAAHCYP3A4MTNR1B | |
| SCHEMBL29512574 | 0.93 | MAPK1 (0.77) | MAPK1ALDH1A1FAAHCYP3A4MTNR1B | |
| Desmedipham SCHEMBL55084 | 0.91 | MAPK1 (0.68) | MAPK1ALDH1A1FAAHCYP3A4MTNR1B | |
| Desmedipham SCHEMBL4895813 | 0.91 | MAPK1 (0.68) | MAPK1ALDH1A1FAAHCYP3A4MTNR1B | |
| Desmedipham SCHEMBL29516752 | 0.91 | MAPK1 (0.68) | MAPK1ALDH1A1FAAHCYP3A4MTNR1B | |
| Phenmedipham SCHEMBL8489570 | 0.89 | CYP3A4 (1.00) | MAPK1ALDH1A1FAAHCYP3A4MAPT | |
| Phenmedipham SCHEMBL29516822 | 0.89 | CYP3A4 (1.00) | MAPK1ALDH1A1FAAHCYP3A4MAPT | |
| Phenmedipham SCHEMBL54580 | 0.89 | CYP3A4 (1.00) | MAPK1ALDH1A1FAAHCYP3A4MAPT | |
| Phenmedipham SCHEMBL10647210 | 0.87 | CYP3A4 (0.92) | MAPK1ALDH1A1FAAHCYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180116209-A1 | Liposome Formulations | LIPOTEC LABORATORIES LLC | 2018-05-03 | — | — | US | disclosed |
| US-20160270400-A1 | Liposome-Attractant Formulations | LIPOTEC LABORATORIES LLC | 2016-09-22 | — | — | US | disclosed |
| US-20150150245-A1 | LIPSOME FORMULATIONS | LIPOTEC LABORATORIES LLC (US) | 2015-06-04 | — | — | US | disclosed |
| US-20100234227-A1 | MICROEMULSION CONCENTRATES | BAYER CROPSCIENCE AG (DE) | 2010-09-16 | — | — | US | disclosed |
| US-20100048516-A1 | PENETRATION ENHANCER FOR FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2010-02-25 | — | — | US | disclosed |
| CN-101621924-A | Oil suspension concentrate with micro-encapsulated agrochemical active ingredients | BAYER CROPSCIENCE AG | 2010-01-06 | — | — | CN | disclosed |
| CN-101583281-A | Penetration enhancer for herbicides and safeners | BAYER CROPSCIENCE AG (DE) | 2009-11-18 | — | — | CN | disclosed |
| CN-101562968-A | New microemulsion concentrates | BAYER CROPSCIENCE AG (DE) | 2009-10-21 | — | — | CN | disclosed |
| CN-101448776-A | Glyceride ester derivatives of herbicidal compounds and compositions thereof | NUFARM AUSTRALIA LTD (AU) | 2009-06-03 | — | — | CN | disclosed |
| US-20080176746-A1 | avoids antagonistically reduced activity or overdosage otherwise requiring split applications; by employing an oil suspension concentrate | BAYER CROPSCIENCE AG (DE) | 2008-07-24 | — | — | US | disclosed |
| US-20030208073-A1 | Substituted N-aryl nitrogen-containing heterocyclic compounds | LINKER KARL-HEINZ (DE) | 2003-11-06 | — | — | US | disclosed |
| US-5022917-A | Mixture with nitrogeous compounds | MELAMINE CHEMICALS, INC. (US) | 1991-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048516-A1 | PENETRATION ENHANCER FOR FUNGICIDES | DDT, DCPS, TYMP | MAPK1 2200/4885ALDH1A1 3150/4885FAAH 2006/4885 |
| US-20030208073-A1 | Substituted N-aryl nitrogen-containing heterocyclic compounds | NAT1, CYP1B1, CYP1A1 | MAPK1 1591/4885ALDH1A1 138/4885FAAH 631/4885 |
| US-20080176746-A1 | avoids antagonistically reduced activity or overdosage otherwise requiring split applications; by employing an oil suspension concentrate | LIPA, MGLL, ABHD6 | MAPK1 4275/4885ALDH1A1 1862/4885FAAH 195/4885 |
| US-20100234227-A1 | MICROEMULSION CONCENTRATES | ADH1C, MGLL, ADH1A | MAPK1 3638/4885ALDH1A1 869/4885FAAH 245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.